Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
British Journal of Clinical Pharmacology|October 30, 2016
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activationChristopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, et al.
The Journal of Antimicrobial Chemotherapy|July 6, 2019
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation studyKrina Mehta, Shruthi Ravimohan, Jotam G Pasipanodya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2013
Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitisGregory P Bisson, Mooketsi Molefi, Scarlett Bellamy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2019
Declines in Lung Function After Antiretroviral Therapy Initiation in Adults With Human Immunodeficiency Virus and Tuberculosis: A Potential Manifestation of Respiratory Immune Reconstitution Inflammatory SyndromeSara C Auld, Pholo Maenetje, Shruthi Ravimohan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2019
A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and TuberculosisShruthi Ravimohan, Pholo Maenetje, Sara C Auld, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2019
Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/TuberculosisShruthi Ravimohan, Sara C Auld, Pholo Maenetje, et al.
The Journal of Infectious Diseases|August 3, 2013
Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosisShruthi Ravimohan, Neo Tamuhla, Andrew P Steenhoff, et al.
NPJ Precision Oncology|July 18, 2024
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumabHelen Gogas, Shruthi Ravimohan, Antara Datta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2023
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial ResultsAdi Diab, Helen Gogas, Shahneen Sandhu, et al.
Pageof 2